Tag Archives: Endocrinology

Rosiglitazone containing Diabetes Medicines Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – Removal of Some Prescribing and Dispensing Restrictionsincluding Avandia, Avandamet, Avandaryl, and generics AUDIENCE: Family Care, Endocrinology, Cardiology ISSUE: FDA has determined that … Continue reading

Share
Posted in Cardiology, Endocrinology, Family Practice, FDA 2013, FDA Notice | Tagged , , , , , , , , , , , | Comments Off

Incretin Mimetic Drugs for Type 2 Diabetes

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseIncretin Mimetic Drugs for Type 2 Diabetes: Early Communication – Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas   ¬†AUDIENCE: Gastroenterology, Endocrinology, Oncology, Patient ISSUE: … Continue reading

Share
Posted in Endocrinology, FDA 2013, FDA Warning, Gastroenterology, Oncology, Patients | Tagged , , , , , , , , | Comments Off

Aliskiren containing Medications Drug Safety Comunication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseAliskiren-containing Medications: Drug Safety Comunication – New Warning and Contraindication including: Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) Tekturna (aliskiren hemifumarate) Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tekamlo (aliskiren hemifumarate … Continue reading

Share
Posted in Endocrinology, FDA 2012, FDA Safety Communication, Internal Medicine, Pharmacy | Tagged , , , , , , , , , , , , , , , , | Comments Off

Reclast zoledronic acid

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseReclast (zoledronic acid): Drug Safety Communication – New Contraindication and Updated Warning on Kidney Impairment AUDIENCE: Endocrinology, Pharmacy, Patient ISSUE: FDA notified healthcare professionals and patients of an update to … Continue reading

Share
Posted in Endocrinology, FDA 2011, Pharmacy | Tagged , , , , , | Comments Off